Progyny, Inc. Tax Withholding Paid on Stock Awards
Progyny, Inc. (PGNY) reported Tax Withholding Paid on Stock Awards of $7.55 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-07
- Progyny, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $2.70M, a 3.48% increase year-over-year.
- Progyny, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $4.84M, a 35.19% increase year-over-year.
- Progyny, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $7.03M, a 335.98% increase year-over-year.
- Progyny, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $2.63M, a 18.40% increase year-over-year.
- Progyny, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $15.85M, a 32.06% increase from fiscal 2024.
- Progyny, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $12.00M, a 30.23% decline from fiscal 2023.
- Progyny, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $17.20M, a 42.28% increase from fiscal 2022.
- Progyny, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $12.09M, a 32.71% decline from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $7.55M 10-Q · filed 2026-08-07 | $14.57M derived: sum of 3 quarters · filed 2026-08-07 | $17.20M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $4.84M 10-Q · filed 2026-05-08 | $11.87M derived: sum of 2 quarters · filed 2026-05-08 | $14.50M derived: sum of 3 quarters · filed 2026-05-08 | $17.11M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $7.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $9.65M derived: sum of 2 quarters · filed 2026-02-27 | $12.27M derived: sum of 3 quarters · filed 2026-08-07 | $15.85M 10-K · filed 2026-02-27 |
| 2025-09-30 | $2.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $5.24M derived: sum of 2 quarters · filed 2026-08-07 | $8.82M 10-Q · filed 2025-11-07 | $10.43M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $2.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $6.20M 10-Q · filed 2026-08-07 | $7.81M derived: sum of 3 quarters · filed 2026-08-07 | $10.02M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $3.58M 10-Q · filed 2026-05-08 | $5.20M derived: sum of 2 quarters · filed 2026-05-08 | $7.41M derived: sum of 3 quarters · filed 2026-05-08 | $10.63M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $3.83M derived: sum of 2 quarters · filed 2026-02-27 | $7.04M derived: sum of 3 quarters · filed 2026-02-27 | $12.00M 10-K · filed 2026-02-27 |
| 2024-09-30 | $2.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $5.43M derived: sum of 2 quarters · filed 2025-11-07 | $10.39M 10-Q · filed 2025-11-07 | $17.09M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $3.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $8.17M 10-Q · filed 2025-08-08 | $14.87M derived: sum of 3 quarters · filed 2026-02-27 | $17.95M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $4.96M 10-Q · filed 2025-05-09 | $11.65M derived: sum of 2 quarters · filed 2026-02-27 | $14.73M derived: sum of 3 quarters · filed 2026-02-27 | $18.34M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $9.77M derived: sum of 2 quarters · filed 2026-02-27 | $13.38M derived: sum of 3 quarters · filed 2026-02-27 | $17.20M 10-K · filed 2026-02-27 |
| 2023-09-30 | $3.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $6.69M derived: sum of 2 quarters · filed 2024-11-12 | $10.50M 10-Q · filed 2024-11-12 | $14.64M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $3.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $7.43M 10-Q · filed 2024-08-07 | $11.56M derived: sum of 3 quarters · filed 2025-03-03 | $13.88M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $3.81M 10-Q · filed 2024-05-10 | $7.95M derived: sum of 2 quarters · filed 2025-03-03 | $10.27M derived: sum of 3 quarters · filed 2025-03-03 | $12.92M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $4.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $6.45M derived: sum of 2 quarters · filed 2025-03-03 | $9.10M derived: sum of 3 quarters · filed 2025-03-03 | $12.09M 10-K · filed 2025-03-03 |
| 2022-09-30 | $2.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $4.97M derived: sum of 2 quarters · filed 2023-11-08 | $7.96M 10-Q · filed 2023-11-08 | $12.82M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $2.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $5.63M 10-Q · filed 2023-08-04 | $10.49M derived: sum of 3 quarters · filed 2024-02-29 | $14.31M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $2.99M 10-Q · filed 2023-05-09 | $7.85M derived: sum of 2 quarters · filed 2024-02-29 | $11.66M derived: sum of 3 quarters · filed 2024-02-29 | $17.43M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $4.86M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $8.68M derived: sum of 2 quarters · filed 2024-02-29 | $14.44M derived: sum of 3 quarters · filed 2024-02-29 | $17.97M 10-K · filed 2024-02-29 |
| 2021-09-30 | $3.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $9.58M derived: sum of 2 quarters · filed 2022-11-04 | $13.11M 10-Q · filed 2022-11-04 | $15.62M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $5.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $9.29M 10-Q · filed 2022-08-05 | $11.80M derived: sum of 3 quarters · filed 2023-03-01 | $14.13M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $3.52M 10-Q · filed 2022-05-06 | $6.03M derived: sum of 2 quarters · filed 2023-03-01 | $8.36M derived: sum of 3 quarters · filed 2023-03-01 | |
| 2020-12-31 | $2.51M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $4.83M derived: sum of 2 quarters · filed 2023-03-01 | $8.93M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $2.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $6.42M 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | $4.10M 10-Q · filed 2021-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |